245 related articles for article (PubMed ID: 10645101)
1. Paraoxonase (PON1) polymorphism & its relation with lipids in north west Indian Punjabis.
Singh S; Verma M; Nain CK; Leelamma CO; Goel RC
Indian J Med Res; 1999 Oct; 110():133-7. PubMed ID: 10645101
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase polymorphism in northwestern Indians.
Singh S; Verma M; Nain CK; Co L; Goel RC; Sharma BK
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):545-8. PubMed ID: 9799059
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
Singh S; Venketesh S; Verma JS; Verma M; Lellamma CO; Goel RC
Indian J Med Res; 2007 Jun; 125(6):783-7. PubMed ID: 17704557
[TBL] [Abstract][Full Text] [Related]
4. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
[TBL] [Abstract][Full Text] [Related]
5. Relationship of paraoxonase and serum lipids in Taiwan.
Lin TJ; Yang DY; Jiang DD; Hung DZ; Hsu CL; Tsai MS
Kaohsiung J Med Sci; 2002 Mar; 18(3):127-33. PubMed ID: 12149827
[TBL] [Abstract][Full Text] [Related]
6. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
Agachan B; Yilmaz H; Karaali Z; Isbir T
Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
[TBL] [Abstract][Full Text] [Related]
9. Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
Yamada A; Shoji T; Tahara H; Emoto M; Nishizawa Y
Metabolism; 2001 Jul; 50(7):805-11. PubMed ID: 11436186
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
Sampson MJ; Braschi S; Willis G; Astley SB
Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770
[TBL] [Abstract][Full Text] [Related]
11. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
12. Determination of paraoxonase (PON1) status requires more than genotyping.
Richter RJ; Furlong CE
Pharmacogenetics; 1999 Dec; 9(6):745-53. PubMed ID: 10634137
[TBL] [Abstract][Full Text] [Related]
13. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
[TBL] [Abstract][Full Text] [Related]
14. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients.
Tomás M; Sentí M; García-Faria F; Vila J; Torrents A; Covas M; Marrugat J
Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2113-9. PubMed ID: 10978257
[TBL] [Abstract][Full Text] [Related]
15. Effect of physical activity on lipid levels in a population-based sample of men with and without the Arg192 variant of the human paraoxonase gene.
Sentí M; Aubó C; Elosua R; Sala J; Tomás M; Marrugat J
Genet Epidemiol; 2000 Mar; 18(3):276-86. PubMed ID: 10723110
[TBL] [Abstract][Full Text] [Related]
16. The risk of coronary artery disease in population of Taiwan is associated with Cys-Ser 311 polymorphism of human paraoxonase (PON)-2 gene.
Pan JP; Lai ST; Chiang SC; Chou SC; Chiang AN
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):415-21. PubMed ID: 12433026
[TBL] [Abstract][Full Text] [Related]
17. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase phenotype distribution in a healthy Iranian population.
Sepahvand F; Shafiei M; Ghaffari SM; Rahimi-Moghaddam P; Mahmoudian M
Basic Clin Pharmacol Toxicol; 2007 Aug; 101(2):104-7. PubMed ID: 17651311
[TBL] [Abstract][Full Text] [Related]
19. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A
Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476
[TBL] [Abstract][Full Text] [Related]
20. The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.
Ombres D; Pannitteri G; Montali A; Candeloro A; Seccareccia F; Campagna F; Cantini R; Campa PP; Ricci G; Arca M
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1611-6. PubMed ID: 9763534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]